BCL11A and COVID-19: BCL11A was reported to be associated with adaptive and innate immunity, especially for dendritic cell and lymphoid development, and genome-wide association studies demonstrated that this gene is participated in immune-mediated inflammatory disease such as COVID-19 and autoimmune diseases (50–53).